Tenax Therapeutics, Inc.

Release Summary

Tenax Therapeutics, Inc. (Nasdaq: TENX), announces board member Anthony A. DiTonno as new Chief Executive Officer, effective June 1, 2018

Tenax Therapeutics, Inc.